Sign In
Buy BCRX
$8.25
-0.0900 (-1.08%)
At Close: Jun 03, 2026
Recap: BioCryst Pharmaceuticals Q1 Earnings
11:42am, Wednesday, 06'th May 2020
Shares of BioCryst Pharmaceuticals (NASDAQ:BCRX) fell 2% in pre-market trading after the company reported Q1 results.Quarterly Results Earnings per share were up 14.29% over the past year to ($0.24),
BioCryst Reports First Quarter 2020 Financial Results and Upcoming Key Milestones
11:00am, Wednesday, 06'th May 2020
BioCryst Pharmaceuticals, Inc. (BCRX) today announced financial results for the first quarter ended March 31, 2020, and provided a corporate update. “This is a transformational year for BioCryst as
The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle
12:00am, Wednesday, 06'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peak
(Biotech Stocks Hitting 52-week Highs May 5)
• Adverum Biotechnologies...
New Composition of Matter Patent Allowance Extends Protection for Berotralstat in U.S. Market by Four Years to 2039
11:00am, Tuesday, 05'th May 2020
BioCryst Pharmaceuticals, Inc. (BCRX) today announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance for patent application 16/671,649. The resulting U.S.
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08:15pm, Monday, 04'th May 2020
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted two newly-hired employees inducement options to purchase an a
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
Investor hope pushes biotech stocks to best monthly gain in two decades
02:28pm, Friday, 01'st May 2020
Strong gains in April pushed the health care sector near year highs on hopes for new Covid treatments.
BioCryst Pharmaceuticals (NASDAQ:BCRX) Shares Gap Up to $3.70
07:12am, Friday, 01'st May 2020
Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) gapped up prior to trading on Thursday . The stock had previously closed at $3.56, but opened at $3.70. BioCryst Pharmaceuticals shares last trad
BioCryst (BCRX) to Report Q1 Earnings: What's in the Cards?
05:17pm, Wednesday, 29'th Apr 2020
During BioCryst's (BCRX) upcoming Q1 earnings call, investor focus will be on the company's progress with the NDA for its HAE drug, Berotralstat, and the study on galidesivir for COVID-19 disease
BioCryst (BCRX) to Report Q1 Earnings: What's in the Cards?
05:17pm, Wednesday, 29'th Apr 2020
During BioCryst's (BCRX) upcoming Q1 earnings call, investor focus will be on the company's progress with the NDA for its HAE drug, Berotralstat, and the study on galidesivir for COVID-19 disease
BioCryst Pharma Tests Drug Similar to Gilead's Remdesivir
05:06pm, Wednesday, 29'th Apr 2020
Investors are snapping up shares of BioCryst, which is testing an antiviral drug similar to Gilead's remdesivir on covid-19 patients.
Will BioCryst Pharmaceuticals (BCRX) Report Negative Earnings Next Week? What You Should Know
04:34pm, Wednesday, 29'th Apr 2020
BioCryst (BCRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will BioCryst Pharmaceuticals (BCRX) Report Negative Earnings Next Week? What You Should Know
04:34pm, Wednesday, 29'th Apr 2020
BioCryst (BCRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Positive remdesivir news 'bodes well' for BioCryst, says JMP Securities BCRX;GILD
03:37pm, Wednesday, 29'th Apr 2020
Positive remdesivir news 'bodes well' for BioCryst, says JMP Securities JMP Securities BCRX GILD
